Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
Saved in:
| Title: | Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. |
|---|---|
| Authors: | Kamperman RG; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. Electronic address: r.kamperman@amsterdamumc.nl., van Leeuwen EM; Department of Experimental Immunology, Amsterdam Institute for Infection & Immunity, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands., Willems M; Department of Neurology, Diakonessenhuis Medical Centre, Utrecht, the Netherlands., van der Kooi AJ; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands., Gelderman KA; Sanquin Diagnostic Services, Amsterdam, the Netherlands., Hamann D; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands., van Lochem EG; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands., Meek B; St. Antonius Hospital, Department of Medical Microbiology and Immunology, Nieuwegein, the Netherlands., van der Molen RG; Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands., Platteel AC; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands., Otten HG; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands., Schreurs MW; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Microvida, Tilburg, the Netherlands., Raaphorst J; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. |
| Corporate Authors: | Dutch Myositis Network |
| Source: | Journal of autoimmunity [J Autoimmun] 2023 Sep; Vol. 139, pp. 103081. Date of Electronic Publication: 2023 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
